Detalhe da pesquisa
1.
First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.
Jpn J Clin Oncol
; 54(4): 452-462, 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271158
2.
First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.
Int J Clin Oncol
; 28(10): 1354-1368, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37548831
3.
Uncommon EGFR mutations conducted with osimertinib in patients with NSCLC: a study protocol of phase 2 study (UNICORN/TCOG1901).
Future Oncol
; 18(5): 523-531, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35034503
4.
Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutations.
Int J Clin Oncol
; 26(6): 1065-1072, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33660106
5.
Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 21(2): 242-249, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838011
6.
Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.
Int J Clin Oncol
; 28(10): 1369-1370, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37684530
7.
Interstitial lung disease associated with amrubicin chemotherapy in patients with lung cancer: a single institutional study.
Jpn J Clin Oncol
; 46(7): 674-80, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27162319
8.
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051.
Sci Rep
; 14(1): 3816, 2024 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360906
9.
Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer.
Lung Cancer
; 191: 107540, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38614069
10.
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial.
J Immunother Cancer
; 12(2)2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38346853
11.
Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 10(3): 315-324, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127362
12.
Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study).
Eur J Cancer
; 184: 62-72, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905770
13.
Study Design and Rationale for Marble Study: A Phase II Trial of Atezolizumab (MPDL3280A) Plus Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Thymic Carcinoma (JTD2101).
Clin Lung Cancer
; 24(7): e247-e253, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37316381
14.
Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations.
JTO Clin Res Rep
; 2(1): 100107, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34589972
15.
Reactivation of TB during administration of durvalumab after chemoradiotherapy for non-small-cell lung cancer: a case report.
Immunotherapy
; 12(6): 373-378, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32314636
16.
[Lung cancer].
Gan To Kagaku Ryoho
; 36(2): 171-5, 2009 Feb.
Artigo
em Japonês
| MEDLINE | ID: mdl-19223731
17.
Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing.
Int J Oncol
; 50(5): 1579-1589, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28350094
18.
Epithelial to mesenchymal transition of lung cancer cells.
J Nippon Med Sch
; 76(4): 181, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19755792
19.
The anticancer effect of histone deacetylase inhibitors and combination with the cytotoxic agents in lung cancer cells: biological analyses for future clinical application.
J Nippon Med Sch
; 76(1): 44-6, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19305113
20.
MiR-134/487b/655 cluster regulates TGF-ß-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
Mol Cancer Ther
; 13(2): 444-53, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24258346